Arix Bioscience PLC (ARIX) 
Notice of Results and Investor Presentation 
14-Sep-2023 / 07:01 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
 
Arix Bioscience plc 
 
Notice of Results and Investor Presentation 
LONDON, 14 September 2023: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), a transatlantic venture capital 
company focused on investing in breakthrough biotechnology companies, will announce its results for the six months 
ended 30 June 2023 and provide an update on the Company's strategic review on Wednesday 27 September 2023. 
Analyst Briefing: 9:00am BST, Wednesday 27 September 2023 
Management will host a virtual briefing for Analysts at 9:00am BST on Wednesday 27 September 2023. Analysts wishing to 
join should register their interest by contacting Powerscourt on arix@powerscourt-group.com or on +44 (0) 20 7290 1050. 
Investor Presentation: 1:00pm BST, Wednesday 27 September 2023 
Management will be hosting a live presentation and Q&A session via the online platform, Investor Meet Company, at 
1:00pm BST on Wednesday 27 September 2023. 
The presentation is open to analysts and all existing and potential shareholders. Questions can be submitted pre-event 
via the Investor Meet Company dashboard or at any time during the live presentation via the "Ask a Question" function. 
Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/arix-bioscience-plc/ 
register-investor 
Investors who already follow Arix on the Investor Meet Company platform will automatically receive an invitation to the 
event. 
 
[ENDS] 
 
Enquiries 
For more information on Arix, please contact: 
 
Arix Bioscience plc 
+44 (0)20 7290 1050 
ir@arixbioscience.com 
 
Powerscourt Group 
Sarah MacLeod, Ibrahim Khalil, Nick Johnson 
+44 (0)20 7250 1446 
arix@powerscourt-group.com 
 
About Arix Bioscience plc 
Arix Bioscience plc is a transatlantic venture capital company focused on investing in breakthrough biotechnology 
companies around cutting-edge advances in life sciences. 
 
We collaborate with exceptional entrepreneurs and provide the capital, expertise, and networks to help accelerate their 
ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase 
of our industry to a broader range of investors. www.arixbioscience.com 
 
 
=---------------------------------------------------------------------------------------------------------------------- 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
ISIN:           GB00BD045071 
Category Code:  NOR 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:   271281 
EQS News ID:    1725697 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1725697&application_name=news

(END) Dow Jones Newswires

September 14, 2023 02:01 ET (06:01 GMT)

Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Arix Bioscience Charts.
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Arix Bioscience Charts.